Depletion of cellular iron by BPS and ascorbate: Effect on toxicity of adriamycin

Free Radical Biology and Medicine

Volumn 20, Issue 3, 1996, Pages 319-329

  Nyayapati, Sreedevi ^a   Afshan, Gul ^a   Lornitzo, Frank ^a   Byrnes, Robert W ^a   Petering, David H ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Adriamycin; Antioxidants; Cells; Chelators; Doxorubicin; Free radicals; Iron; Iron deficient; Transferrin

Indexed keywords

1,10 PHENANTHROLINE; ANTIOXIDANT; ASCORBIC ACID; CHELATING AGENT; DEFEROXAMINE; DOXORUBICIN; FREE RADICAL; GLUTATHIONE PEROXIDASE; PYRIDOXAL ISONICOTINOYLHYDRAZONE; TRANSFERRIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL STRAIN HL 60; EUGLENA GRACILIS; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON TRANSPORT; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; EUGLENA GRACILIS;

EID: 0029981660     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(96)02054-0     Document Type: Article

References (34)

1. de Mello Felho, A. C.; Meneghini, R. Protection of mammalian cells by o-phenanthroline from lethal and DNA-damaging effects produced by active oxygen species. Biochem. Biophys. Acta 847:82-89; 1985
2. Imlay, J. A.; Chin, S. M.; Linn, S. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 240:640-642; 1988.
3. Krishnamurti, C.; Saryan, L. A.; Petering, D. H. Effects of ethylenediaminetetraacetic acid and 1, 10-phenanthroline on cell proliferation and DNA synthesis of Ehrlich ascites cells. Cancer Res. 40:4092-4099; 1980.
4. Richardson, D.; Ponka, P.; Baker, E. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell. Cancer Res. 54:685-689; 1994.
5. Sillen, L. G.; Martell, A. E. Stability constants supplement No. 1. London: The Chemical Society Burlington House; 1971:676-677.
6. Propper, R. D.; Shurin, S. B.; Nathan, D. G. Desferrioxamine B and iron overload. In: Anderson, W. F.; Hiller, M. C., eds. Development of iron chelators for clinical use. Washington, DC: DHEW Publication No. (NIH) 76-994; 1975:83-114.
7. Byers, B. R.; Arceneauz, J. E. L.; Gaines, B. G.; Sciortino, C. V. Isolation of microbial iron chelators: Some possible effects of their chemotherapeutic use. In: Anderson, W. F.; Hiller, M. C., eds. Development of iron chelators for clinical use. Washington, DC: DHEW Publication No. (NIH) 76-994; 1975:213-228.
8. Radtke, K.; Lornitzo, F. A.; Byrnes, R. W.; Antholine, W. E.; Petering, D. H. Iron requirement for cellular DNA damage and growth inhibition by hydrogen peroxide and bleomycin. Biochem. J. 302:655-664; 1994.
9. Keizer, H. G.; Pinedo, H. M.; Schurhuis, G. J.; Joenje, H. Doxorubicin (Adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol. Ther. 47:219-231; 1990.
10. Wallace, K. B. Nonenzymatic oxygen activation and stimulation of lipid peroxidation by doxorubicin-copper. Toxicol. Appl. Pharmacol. 86:69-79; 1986.
11. Gelvan, D.; Samuni, A. Reappraisal of the association between adriamycin and iron. Cancer Res. 48:5645-5649; 1988.
12. Massoud, S. S.; Jordan, R. B. Kinetic and equilibrium studies of the complexation of aqueous iron(III) by daunomycin, quinizarin, and quinizarin-2-sulfonate. Inorgan. Chem. 30:4851-4856; 1991.
13. Eliot, H.; Gianni, L.; Myers, C. Oxidative destruction of DNA by the adriamycin-iron complex. Biochemistry 23:928-936; 1984.
14. Gianni, L.; Zweier, L. L.; Levy, A.; Myers C. E. Characterization of the cycle of iron-mediated electron transfer from adriamycin to molecular oxygen. J. Biol. Chem. 260:6820-6828; 1985.
15. Tewey, K. M.; Rowe, T. C.; Yang, L.; Halligan, B. D.; Liu, L. F. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226:466-468; 1984.
16. Lyman, S.; Taylor, P.; Lornitzo, F.; Weir, A.; Stone, D.; Antholine, W. E.; Petering, D. H. Activity of bleomycin in iron-and copper-deficient cells. Biochem. Pharmacol. 38:4273-4282; 1989.
17. Loven, P.; Leeper, D. B.; Oberley, L. W. Superoxide dismutase levels in Chinese hamster ovary cells and ovarian carcinoma cells after hyperthermia or exposure to cycloheximide. Cancer Res. 45:3029-3033; 1985.
18. Aebi, H. E. Catalase. In: Bergmeyer, H. U., ed. Methods of enzymatic analysis, 3rd ed. vol. III. Weinheim: Verlag-Chemie; 1983:277-282.
19. Geiger, P. G.; Thomas, J. P.; Girotti, A. W. Lethal damage to murine L1210 cells by exogenous lipid hydroperoxides: Protective role of glutathione-dependent selenoperoxidases. Arch. Biochem. Biophys. 288:671-680; 1991.
20. Griffith, O. W. Glutathione and glutathione disulphide. In: Bergmeyer, H. U., ed. Methods of enzymatic analysis, 3rd ed. vol. 9. Weinheim: Verlag-Chemie; 1985:521-529.
21. Omaye, D. W.; Emery, G.; Maynard, J. E. Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol. 62:3-11; 1979.
22. Marques, H. M.; Watson, D. I.; Egan, T. J. Kinetics of iron removal from human serum monoferric transferrins by citrate. Inorg. Chem. 30:3756-3762; 1991.
23. Egan, T.; Ross, D. C.; Purves, L. R.; Adams, P. A. Mechanism of iron release from human serum C-terminal monoferric transferrin to pyrophosphate: Kinetic discrimination between alternative mechanisms, Inorg. Chem. 31:1994-1998; 1992.
24. 2-. J. Biol. Chem. 254:8847-8854; 1979.
25. Ankel, E.; Petering, D. H. Iron-chelating agents and the reductive removal of iron from transferrin. Biochem. Pharmacol. 29:1833-1837; 1980.
26. Chitambar, C. R.; Zivkovic-Gilgenbach, Z. Influence of cellular iron status on the release of soluble transferrin receptor from human promyelocytic leukemic HL-60 cells. J. Lab. Clin. Med. 116:345-353; 1990.
27. Rodgers, J. T.; Bridges, K. R.; Durmowicz, G. P.; Glass, J.; Auron, P. E.; Munro, H. N. Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1. J. Biol Chem. 265:14572-14578; 1990.
28. de Mello Filho, A. C.; Hoffmann, M. E.; Meneghini, R. Cell killing and DNA damage by hydrogen peroxide are mediated by intracellular iron. Biochem. J. 218:273-275; 1984.
29. Shiloh, H.; Iancu, T. C.; Bauminger, E. R.; Link, G.; Pinson, A.; Hershko, C. Desferoxamine-induced iron mobilization and redistribution of myocardial iron in cultured rat heart cells: Studies of the chelatable iron pool by electron microscopy and Mössbauer spectroscopy. J. Lab. Clin. Med. 114:428-436; 1992.
30. Byrnes, R. W.; Petering, D. H. Inhibition of bleomycin-induced cellular DNA strand scission by 1,10,phenanthroline. Biochem. Pharmacol. 41:1241-1248; 1991.
31. Graham, D. R.; Sigman, D. S. Zinc ion in Escherichia coli DNA polymerase: A reinvestigation. Inorg. Chem. 23:4188-4191; 1984.
32. Winkler, B. S.; Orselli, S. M.; Rex, T. S. The redox couple between glutathione and ascorbic acid: A chemical and physiological perspective. Fr. Radiat. Biol. Med. 17:333-349: 1994.
33. Petering, D. H.; Byrnes, R. W.; Antholine, W. E. The role of redox-active metals in the mechanism of action of bleomycin. Chem.-Biol. Interact. 73:133-182; 1990.
34. Deffie, A. M.; Batra, J. K.; Goldenberg, G. J. Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines. Cancer Res. 49:58-62: 1989.